Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform

Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform

BackgroundCystic fibrosis (CF) is a chronic multi-systemic disease that requires a complex daily treatment regimen. Therefore, there is sub-optimal adherence to CF therapies, and it was shown to impact its clinical and economic burden. Cystic fibrosis transmembrane conductance regulator modulators (...

Full description

Bibliographic Details
Main Authors: Karin Yaacoby-Bianu, Malena Cohen-Cymberknoh, David Shoseyov, Tal Lavi, Ana Ostrovski, Michal Shteinberg, Galit Livnat
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Pediatrics
Subjects:
cystic fibrosis
CFTR modulators
elexacaftor/tezacaftor/ivacaftor
medication delivery platforms
adherence to chronic treatment
remote patient monitoring
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1300968/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2023.1300968/full

Similar Items